0001214659-24-004391.txt : 20240312
0001214659-24-004391.hdr.sgml : 20240312
20240312134617
ACCESSION NUMBER: 0001214659-24-004391
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240309
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wargacki Stephen
CENTRAL INDEX KEY: 0001960165
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 24741394
MAIL ADDRESS:
STREET 1: C/O AQUESTIVE THERAPEUTICS, INC.
STREET 2: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001398733
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208623253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-941-1900
MAIL ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: MonoSol Rx, Inc.
DATE OF NAME CHANGE: 20070507
4
1
marketforms-65149.xml
PRIMARY DOCUMENT
X0508
4
2024-03-09
0001398733
Aquestive Therapeutics, Inc.
AQST
0001960165
Wargacki Stephen
C/O AQUESTIVE THERAPEUTICS, INC.
30 TECHNOLOGY DRIVE
WARREN
NJ
07059
false
true
false
false
SVP, Research & Development
0
Common Stock
2024-03-09
4
F
false
11269
4.88
D
259650
D
Common Stock
2024-03-10
4
F
false
1687
4.88
D
257963
D
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.
/s/ Lori Braender, as Attorney-In-Fact
2024-03-12